← Back to Clinical Trials
Recruiting NCT07293676

NCT07293676 IASTM and Vibration Effects on Pain, Functionality, and Kinesiophobia in Lumbar Disc Herniation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07293676
Status Recruiting
Phase
Sponsor Istanbul Medipol University Hospital
Condition Vibration
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2026-01-05
Primary Completion 2026-05-10

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
ExerciseIASTMPercussion massage therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 45 participants in total. It began in 2026-01-05 with a primary completion date of 2026-05-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to investigate the effects of Instrument-Assisted Soft Tissue Mobilization and vibration massage therapy on pain, functionality, and kinesiophobia in individuals with lumbar disc herniation.

Eligibility Criteria

Inclusion Criteria: * Individuals between 30 and 60 years of age * Individuals diagnosed with lumbar disc herniation at the protrusion level * Individuals with no cognitive, intellectual, or mental impairments and who are able to express themselves * Individuals with a VAS score greater than 5 * Individuals experiencing pain for at least 3 months Exclusion Criteria: * Individuals with a history of lumbar surgery * Individuals who are pregnant * Individuals who have had a spinal tumor or any other malignancy within the past six months * Individuals who have received physiotherapy for low back pain within the last six months * Individuals with orthopedic conditions such as fractures * Individuals diagnosed with neurological, rheumatological, or psychological disorders * Individuals with diagnoses such as infection, spondylosis, spondylolysis, osteoporosis, or ankylosing spondylitis will be excluded from the study.

Contact & Investigator

Central Contact

İlayda Gundogmus

✉ ilayda.gundogmus@std.medipol.edu.tr

📞 +90 534 434 99 34

Principal Investigator

Burak Menek

PRINCIPAL INVESTIGATOR

Uludag University

Frequently Asked Questions

Who can join the NCT07293676 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, up to 60 Years, studying Vibration. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07293676 currently recruiting?

Yes, NCT07293676 is actively recruiting participants. Contact the research team at ilayda.gundogmus@std.medipol.edu.tr for enrollment information.

Where is the NCT07293676 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07293676 clinical trial?

NCT07293676 is sponsored by Istanbul Medipol University Hospital. The principal investigator is Burak Menek at Uludag University. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology